糖皮质激素受体 (GR 或 GCR) 也称为 NR3C1(核受体亚家族蛋白 3,C 组,成员 1),是皮质醇和其他糖皮质激素结合的受体。GR 在体内几乎每个细胞中表达,并调节控制发育、代谢和免疫反应的基因。当糖皮质激素受体与糖皮质激素结合时,其主要作用机制是调节基因转录。未结合的受体位于细胞的胞质溶胶中。受体与糖皮质激素结合后,受体-糖皮质激素复合物可以采取两种途径中的任一种。激活的 GR 复合物通过阻止其他转录因子从胞质溶胶转移到细胞核中来上调细胞核中抗炎蛋白的表达或抑制细胞质中促炎蛋白的表达。Dexamethasone 为 GR 激动剂,RU486、醋酸环丙孕酮为GR拮抗剂,孕酮、脱氢表雄酮等对 GR 有拮抗作用。
Glucocorticoid Receptor (GR, or GCR) also known as NR3C1 (nuclear receptor subfamily 3, group C, member 1) is the receptor to which cortisol and other glucocorticoids bind. The GR is expressed in almost every cell in the body and regulates genes controlling the development, metabolism, and immune response. When the glucocorticoid receptor binds to glucocorticoids, its primary mechanism of action is the regulation of gene transcription. The unbound receptor resides in the cytosol of the cell. After the receptor is bound to glucocorticoid, the receptor-glucorticoid complex can take either of two paths. The activated GR complex up-regulates the expression of anti-inflammatory proteins in the nucleus or represses the expression of pro-inflammatory proteins in the cytosol by preventing the translocation of other transcription factors from the cytosol into the nucleus. Dexamethasone is an agonist, and RU486 and cyproterone acetate are antagonists of the GR. Also, progesterone and DHEA have antagonist effects on the GR.
Tetrahydrocortisone 是内源性糖皮质激素经 AKR1D1 (5β-还原酶) 催化生成的皮质类固醇,其生成由 AKR1D1 介导并受糖皮质激素受体 (GR) 调控,作为糖皮质激素灭活代谢的终产物之一参与维持体内糖皮质激素代谢稳态,可用于非酒精性脂肪性肝病 (NAFLD)、2 型糖尿病等代谢性疾病的机制研究,同时可作为体内 AKR1D1 活性及糖皮质激素代谢状态的生物标志物。
© 2026 MolStrong. 保留所有权利。粤ICP备2023004355号
可通过CAS号进行批量搜索,一行一个CAS号